You are here: Home » Companies » News
Business Standard

Unichem Labs allergic rhinitis drug gets tentative approval from USFDA

The product will be commercialised from Unichem's Goa plant on receipt of final approval

Press Trust of India  |  New Delhi 

Unichem Lab

Tuesday said it has received tentative approval from the US health regulator for its generic copy of allergic rhinitis Johnson & Johnson Consumer Inc's used for treating allergic rhinitis.

The tentative nod by the US Food and Drug Administration (USFDA) is for the company's Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride extended-release tablets, 5 mg/120 mg, said in a regulatory filing.

The over the counter product is also indicated as a nasal decongestant.

The product will be commercialised from Unichem's Goa plant on receipt of final approval, it added.

First Published: Tue, May 07 2019. 12:40 IST
RECOMMENDED FOR YOU